Veenat Imatinib – 100 mg, 400 mg Tablets

At a Glance

Brand name: Veenat

Generic name: Imatinib mesylate

Active ingredient: Imatinib

Strengths & packs: Veenat 100 mg (1 pack / 120 tablets); Veenat 400 mg (1 pack / 30 tablets)

Dosage form: Oral film-coated tablets

Main indication: Philadelphia chromosome–positive chronic myeloid leukemia (CML) and other indicated malignancies

Therapeutic class: Tyrosine kinase inhibitor (TKI)

Use in therapy: First-line and subsequent treatment for Ph+ CML and selected gastrointestinal stromal tumors (GIST)

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Veenat 100 mg and Veenat 400 mg tablets are
generic imatinib mesylate medicines used as part of targeted therapy for certain leukemias and solid tumors.
Imatinib is a well-known tyrosine kinase inhibitor that transformed the management of
Philadelphia chromosome–positive chronic myeloid leukemia (CML) and specific
gastrointestinal stromal tumors (GIST). This variable product listing combines both strengths so you can
buy Veenat online in either 100 mg (120 tablets) or 400 mg (30 tablets) form,
according to your oncologist’s prescription.

Veenat imatinib tablets are typically prescribed as long-term therapy. Many patients with chronic phase CML take
imatinib tablets daily for years to maintain remission and control leukemic cell counts.
Veenat 100 mg tablets are useful when flexible dosing or smaller adjustments are required, while
Veenat 400 mg tablets can provide a convenient standard-dose option. Because
Veenat is a generic imatinib product, it offers the same active ingredient as branded imatinib at more accessible USD pricing,
which is important when treatment continues over extended periods.

Each Veenat tablet contains imatinib mesylate corresponding to the stated strength of imatinib (100 mg or 400 mg).
The tablets are taken orally once or sometimes twice daily, depending on your prescribed total daily dose. When you
order Veenat online from Generic Meds Mart, you receive imatinib tablets supplied by licensed manufacturers and authorised distributors
that follow recognised Good Manufacturing Practice standards. The medicine is packed in discreet outer packaging to protect your privacy while preserving all original
product details on the blisters and cartons.

This Veenat 100 mg (120 tabs) / 400 mg (30 tabs) product is intended only for patients under the care of a haematologist or oncologist who has clearly
recommended imatinib therapy. Generic Meds Mart does not provide diagnosis or adjust treatment plans; this page is designed to support
informed discussions with your specialist about ongoing access to generic imatinib tablets.

Key Uses

Veenat imatinib tablets are typically used for the following indications under specialist supervision:

• Treatment of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in chronic, accelerated or blast phase as directed
• Treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in selected cases
• Treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) expressing KIT (CD117)
• Treatment of certain other rare malignancies where imatinib is specifically recommended in the treatment protocol

Your specialist will determine the exact indication for Veenat 100 mg or Veenat 400 mg,
your total daily dose and how long imatinib therapy should continue.

How Imatinib Works in Chemotherapy

Imatinib is a targeted anticancer agent often grouped within modern chemotherapy and systemic treatments.
Veenat contains imatinib, a tyrosine kinase inhibitor (TKI) that blocks abnormal signalling from specific kinases such as BCR-ABL in CML
and KIT in many GIST tumors.

Veenat imatinib tablets selectively inhibit these overactive tyrosine kinases by blocking their ATP-binding site.
This interference disrupts signalling pathways that drive uncontrolled cell growth and survival. In
chronic myeloid leukemia, this can reduce leukemic cell counts and help achieve hematologic and cytogenetic responses.
In GIST, targeted inhibition of KIT can shrink or stabilise tumours that depend on this signalling pathway,
improving outcomes compared with non-targeted therapies.

Because imatinib acts as a targeted TKI rather than a traditional cytotoxic drug, its side effect profile differs from standard chemotherapy.
However, Veenat remains a potent anticancer treatment that requires regular monitoring and supervision by an experienced haematologist or oncologist.

Dosage & Administration

Veenat 100 mg and Veenat 400 mg imatinib tablets must always be taken exactly as prescribed by your specialist.
Daily dosing, timing and duration of therapy depend on your diagnosis, disease phase, response and tolerance.

• Take Veenat tablets by mouth with a large glass of water; some patients may be advised to take doses with food to reduce stomach discomfort.
• Swallow the tablets whole. Do not crush, split or chew Veenat tablets unless your doctor or pharmacist has given specific instructions.
• The total daily dose may be taken once daily or divided into two doses, depending on your prescription and tolerance.
• Do not change your dose, switch between Veenat 100 mg and Veenat 400 mg, or stop taking imatinib without clear instructions from your specialist.
• If you miss a dose, follow your doctor’s advice; do not double the next dose to make up for a missed tablet unless your oncologist has recommended it.

Your haematologist or oncologist will schedule regular blood tests and other assessments to monitor your response to
Veenat imatinib therapy and to adjust the dose if necessary.

Precautions

Before starting Veenat, tell your doctor about your complete medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of liver disease, kidney impairment or significant cardiac disease
• Pre-existing fluid retention, swelling, heart failure or shortness of breath
• Previous or current gastrointestinal bleeding or major stomach or bowel disease
• Use of other anticancer drugs, immunosuppressants or biologic therapies
• Use of strong CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with imatinib
• Use of paracetamol, anticoagulants or other medicines that may require careful monitoring when combined with Veenat imatinib tablets

Imatinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Veenat. Your specialist will decide what monitoring schedule is needed in your case.

Imatinib Side Effects

Common side effects

Many patients experience side effects when starting Veenat imatinib tablets, especially during the first months of treatment.
Common reactions may include:

• Mild to moderate nausea, vomiting or stomach discomfort
• Diarrhea or, in some cases, constipation
• Fluid retention with swelling of ankles, legs or around the eyes
• Muscle cramps, bone pain or joint discomfort
• Fatigue, weakness or general tiredness
• Mild skin rash or itching

These side effects are often manageable with supportive care or dose adjustments, but you should inform your oncology team about any persistent or troublesome symptoms.

Serious side effects

Some side effects of imatinib are less common but more serious and require urgent medical attention. Serious reactions may include:

• Marked fluid retention with sudden weight gain, shortness of breath or worsening swelling, which may indicate heart or lung complications
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe gastrointestinal symptoms, including severe abdominal pain, bloody stools or vomiting blood
• Significant changes in blood counts, with fever, frequent infections, easy bruising or unusual bleeding
• Severe skin reactions, widespread rash, blistering or mucosal involvement

If you experience any of these serious symptoms while taking Veenat 100 mg or Veenat 400 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Veenat tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excessive heat.
• Keep the tablets in their original blisters and cartons until use to protect them from moisture and light.
• Keep Veenat imatinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired imatinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Veenat 100 mg  and Veenat 400 mg imatinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Veenat online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic imatinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your treating specialist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Veenat 100 mg and 400 mg imatinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of a haematologist or oncologist.
Before you order Veenat online, ensure that you have a valid prescription or written treatment plan specifying imatinib, the required daily dose and intended duration of therapy.

Select the prescribed strength — Veenat 100 mg (1 pack / 120 tablets) or Veenat 400 mg (1 pack / 30 tablets) —
choose the appropriate quantity, add Veenat to your cart and complete the secure checkout process. Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.

Sutent Sunitinib Capsules (12.5 mg, 25 mg, 50 mg)

At a Glance

Generic Name: Sunitinib (sunitinib malate)

Brand Name: Sutent

Strength & Pack Size: 12.5 mg (1 pack / 7 caps), 25 mg (1 pack / 7 caps), 50 mg (1 pack / 28 caps, EG)

Dosage Form & Route: Oral capsule, swallowed whole with water

Therapeutic Class: Multi-targeted tyrosine kinase inhibitor (TKI), VEGFR and PDGFR inhibitor (targeted anticancer therapy)

Primary Indications: Metastatic renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) after prior therapy, pancreatic neuroendocrine tumors (pNET) in appropriate patients

Usual Adult Dose: Defined by an oncologist based on indication, treatment goals, and tolerability

Prescription Status: Prescription-only medicine

Storage: Store in original packaging as directed on the label; protect from moisture and keep out of reach of children

Product Description

Sutent contains sunitinib, an oral targeted anticancer medicine used in specialist-led treatment plans for metastatic renal cell carcinoma, gastrointestinal stromal tumor, and pancreatic neuroendocrine tumors when an oncologist confirms that sunitinib therapy is appropriate. Sutent sunitinib capsules are offered in multiple strengths to support individualized dosing and monitoring, including 12.5 mg and 25 mg packs (1 pack / 7 caps) and a 50 mg pack (1 pack / 28 caps, EG). If you plan to buy Sutent online, make sure your diagnosis, intended treatment cycle, and monitoring schedule are confirmed by your cancer care team.

Sunitinib is widely referenced as a VEGFR-targeted TKI that can help control tumor growth by reducing signaling involved in tumor blood vessel formation and tumor cell proliferation. Because patient factors vary, your oncologist considers prior therapies, liver and kidney function, blood pressure history, heart risk, bleeding risk, and potential drug interactions before prescribing Sutent. Patients and caregivers managing a prescription-led oncology plan often search for this treatment as Sutent sunitinib capsules online when coordinating refills and maintaining continuity of care, especially when comparing options by sunitinib price and pack size.

Generic Meds Mart supplies Sutent in original packaging sourced through licensed channels. Packs are labeled for verification with the product name, active ingredient, strength, batch number, and expiry date so clinics and pharmacies can confirm authenticity on receipt. Orders are shipped in discreet outer packaging to support privacy, and worldwide delivery options help patients plan access alongside regular monitoring.

Key Uses

Sutent (sunitinib) is used in oncology care for selected solid tumors where a multi-targeted tyrosine kinase inhibitor approach is clinically appropriate. In metastatic renal cell carcinoma, sunitinib is part of targeted therapy strategies aimed at slowing disease progression within a structured plan that includes blood pressure monitoring, lab checks, and assessment of side effects. In gastrointestinal stromal tumor, sunitinib may be used after prior therapy when defined by specialist guidance. In pancreatic neuroendocrine tumors, sunitinib can be used in appropriate patients as part of longer-term disease control planning under specialist supervision.

Common Searches and Treatment Contexts for Sunitinib

• Sutent for RCC: Sutent (sunitinib) is used in metastatic renal cell carcinoma as targeted therapy within oncologist-managed care and scheduled monitoring.
• Sunitinib for GIST: Sunitinib is used for gastrointestinal stromal tumor in specific settings, typically after prior therapy, with treatment goals and follow-up defined by a specialist.
• Sunitinib for pNET: Sutent is used in pancreatic neuroendocrine tumors in suitable patients as part of a complete oncology treatment plan.
• VEGFR TKI Targeted Therapy: Sunitinib inhibits signaling pathways involved in tumor angiogenesis, which is why it is classified as a VEGFR-targeted tyrosine kinase inhibitor.
• Buy Sutent Online: Patients with a confirmed prescription and monitoring plan may seek reliable access to original-packaging Sutent to support therapy continuity.

How Sunitinib Works in Chemotherapy

Sunitinib works by inhibiting multiple tyrosine kinases involved in tumor growth and tumor blood vessel development, including receptors related to vascular endothelial growth factor (VEGFR) and platelet-derived growth factor (PDGFR). By reducing signaling that supports angiogenesis, sunitinib can limit the formation of new blood vessels that tumors use for oxygen and nutrient supply. This targeted mechanism differs from classic cytotoxic chemotherapy because it focuses on molecular signaling pathways rather than broadly damaging dividing cells.

Because these pathways also affect normal tissues, monitoring is essential. Blood pressure changes, fatigue, gastrointestinal effects, skin reactions, thyroid changes, and blood count abnormalities can occur. Your oncologist balances expected benefit with safety and may adjust the plan based on symptoms and laboratory results.

Dosage & Administration

Sutent capsules must be taken exactly as prescribed by an oncologist. Sutent dosage is individualized and commonly delivered in planned treatment cycles with scheduled assessment and follow-up, depending on the indication and tolerability. Swallow capsules whole with water and take them on the schedule provided by your clinic. Do not open, crush, or chew capsules unless your care team gives a specific alternative instruction.

Drug interactions can be clinically important, so share a complete list of prescription medicines, over-the-counter products, and supplements with your oncologist and pharmacist. If you miss a dose, follow your clinic’s instructions rather than taking extra capsules to compensate.

Precautions

Sunitinib can raise blood pressure and may increase cardiovascular risk in susceptible patients, which is why blood pressure monitoring and periodic clinical review are important. It can also affect blood counts and thyroid function, and liver tests may be monitored during treatment. Some patients may have higher bleeding risk or wound-healing concerns, so planned procedures should be discussed with the treating team.

Serious complications are uncommon but require urgent medical attention, including significant bleeding, severe shortness of breath, chest pain, severe weakness, fainting, or symptoms of liver injury such as jaundice. Pregnancy should be avoided during therapy, and contraception planning should be discussed with a qualified clinician.

Sunitinib Side Effects

Common side effects

Common sunitinib side effects may include fatigue, diarrhea, nausea, reduced appetite, mouth sores, skin or hair changes, hand-foot skin reactions, and elevated blood pressure. Some patients experience changes in taste or thyroid function. Report persistent or worsening symptoms early so your oncology team can guide supportive care.

Serious side effects

Serious side effects require urgent medical attention and may include major bleeding, severe hypertension complications, heart problems, severe infection, significant liver injury, or severe shortness of breath. If you develop alarming symptoms, seek urgent care and inform clinicians that you are taking sunitinib.

Storage

Store Sutent capsules in original packaging as directed on the label, protected from moisture and excessive heat. Keep out of reach of children. Do not use after the expiry date printed on the carton.

Why Buy from Generic Meds Mart

Generic Meds Mart supports access and logistics for specialty oncology medicines such as Sutent (sunitinib). Products are supplied in original packaging sourced through licensed channels with batch and expiry information for verification by clinics and pharmacies. Pricing is displayed in USD, secure checkout supports straightforward ordering, and discreet outer packaging helps protect privacy.

Worldwide delivery options can help patients coordinate refills with monitoring schedules and specialist visits. Generic Meds Mart does not replace your treating oncologist. All clinical decisions about whether Sutent is appropriate, how long to use it, and how to manage side effects must be made by qualified healthcare professionals.

Order Now

Before ordering Sutent from Generic Meds Mart, you should have a confirmed diagnosis and a treatment plan defined by your oncologist for RCC, GIST, or pNET. Your clinic will confirm the appropriate strength and pack size and set a monitoring plan for blood pressure, labs, and side effects. Once your plan is confirmed, select the correct Sutent strength and pack, add it to your cart, and complete secure checkout in USD.

Do not start, stop, or change sunitinib therapy without specialist supervision. If you develop heavy bleeding, chest pain, severe shortness of breath, jaundice, or rapidly worsening symptoms, seek urgent medical care and inform clinicians that you are receiving sunitinib.

FAQ about Sutent (Sunitinib)

Q1: What is Sutent used for?
Sutent contains sunitinib, a targeted tyrosine kinase inhibitor used in specialist-led plans for metastatic renal cell carcinoma, certain gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors in appropriate patients.

Q2: How are Sutent capsules usually taken?
Sutent is taken by mouth on a schedule defined by an oncologist, often as part of planned treatment cycles with monitoring. Follow your clinic’s instructions and do not change the schedule on your own.

Q3: What monitoring is important during sunitinib therapy?
Monitoring often includes blood pressure checks and periodic lab tests such as blood counts, liver tests, and thyroid function, with frequency defined by your oncology team.

Q4: What should I do if I miss a dose?
Follow your clinic’s instructions and do not take extra doses to make up for a missed dose unless your oncologist specifically advises it. If unsure, contact your prescribing team.

Q5: What are common sunitinib side effects?
Common side effects can include fatigue, diarrhea, nausea, mouth sores, skin changes, hand-foot reactions, and high blood pressure. Report persistent or severe symptoms early for specialist guidance.

Q6: Is sunitinib the same as Sutent (Generic Sutent)?
Sunitinib is Generic Sutent – it contains the same active ingredient (sunitinib) as Sutent. They are used for the same indication at the same strength, but may differ in manufacturer, inactive ingredients (excipients), capsule appearance, and packaging. If you are switching between products, confirm the substitution with a qualified healthcare professional.

Imat Imatinib – 100 mg, 400 mg (1 pack / 10 tabs) Tablets

At a Glance

Brand name: Imat

Generic name: Imatinib mesylate

Active ingredient: Imatinib

Strengths & packs: Imat 100 mg (1 pack / 10 tablets); Imat 400 mg (1 pack / 10 tablets)

Dosage form: Oral film-coated tablets

Main indication: Philadelphia chromosome–positive chronic myeloid leukemia (CML) and selected GIST

Therapeutic class: Tyrosine kinase inhibitor (TKI)

Use in therapy: First-line and subsequent targeted therapy for Ph+ CML and indicated solid tumors

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Imat 100 mg and Imat 400 mg tablets are
generic imatinib mesylate medicines used as part of targeted therapy for specific blood cancers and solid tumors.
Imatinib is a tyrosine kinase inhibitor (TKI) that has transformed the management of
Philadelphia chromosome–positive chronic myeloid leukemia (CML) and many gastrointestinal stromal tumors (GIST).
This variable product listing combines both strengths so you can buy Imat online in either
100 mg (1 pack / 10 tablets) or 400 mg (1 pack / 10 tablets) according to your specialist’s prescription.

Imat imatinib tablets are commonly prescribed as long-term daily therapy. In chronic phase CML,
imatinib tablets can help control leukemic cell counts, maintain remission and support long-term disease control.
Imat 100 mg tablets are useful when flexible dosing or smaller adjustments are needed, while
Imat 400 mg tablets offer a convenient standard-dose option. Because
Imat is a generic imatinib product, it contains the same active ingredient as branded imatinib but is often available at more accessible USD pricing,
which is important for extended treatment courses.

Each Imat tablet contains imatinib mesylate corresponding to the stated strength of imatinib (100 mg or 400 mg).
The tablets are taken orally with water, usually once daily or split into two doses, depending on the total daily dose and tolerability.
When you order Imat online from Generic Meds Mart, you receive imatinib tablets supplied by licensed manufacturers and authorised distributors
that follow recognised Good Manufacturing Practice standards. Original packaging retains full product details, while outer shipping materials are plain and discreet.

This Imat 100 mg (1 pack / 10 tabs) / 400 mg (1 pack / 10 tabs) product is intended only for patients under the care of a haematologist or oncologist
who has clearly recommended imatinib therapy. Generic Meds Mart does not provide diagnosis or change treatment plans;
this page is designed to support informed discussions with your specialist about access to generic imatinib tablets.

Key Uses

Imat imatinib tablets are generally used for the following indications under specialist supervision:

• Treatment of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in chronic, accelerated or blast phase as directed
• Treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in selected cases
• Treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) expressing KIT (CD117)
• Treatment of other rare malignancies where imatinib is specifically recommended in recognised protocols

Your specialist will determine whether Imat 100 mg or Imat 400 mg is appropriate, how many tablets you should take per day and
how long imatinib therapy should continue.

How Imatinib Works in Chemotherapy

Imatinib is a targeted anticancer agent often grouped within modern systemic chemotherapy and targeted therapy regimens.
Imat contains imatinib, a tyrosine kinase inhibitor (TKI) that blocks abnormal signalling from specific tyrosine kinases such as BCR-ABL in CML
and KIT in many GIST tumours.

Imat imatinib tablets work by binding to these overactive tyrosine kinases and blocking their ATP-binding sites.
This disrupts signalling pathways that drive uncontrolled cancer cell growth and survival. In
chronic myeloid leukemia, this targeted inhibition can reduce leukemic cell counts and support long-term remission.
In GIST, inhibition of KIT can shrink or stabilise tumours that depend on this pathway.

Because imatinib acts as a targeted TKI rather than a traditional cytotoxic drug, its side effect profile differs from standard chemotherapy.
However, Imat is still a potent anticancer medicine and must be monitored carefully by an experienced haematologist or oncologist.

Dosage & Administration

Imat 100 mg and Imat 400 mg imatinib tablets must always be taken exactly as prescribed by your specialist.
Daily dosing, timing and duration of therapy depend on your diagnosis, disease phase, response and tolerance.

• Take Imat tablets by mouth with a large glass of water; some patients are advised to take doses with food to reduce stomach discomfort.
• Swallow the tablets whole. Do not crush, split or chew Imat tablets unless your doctor or pharmacist has given specific instructions.
• The total daily dose may be taken once daily or divided into two doses, depending on your prescription and tolerance.
• Do not change your dose, switch between Imat 100 mg and Imat 400 mg, or stop taking imatinib without clear instructions from your specialist.
• If you miss a dose, follow your doctor’s advice; do not double the next dose to make up for a missed tablet unless your oncologist has recommended it.

Your haematologist or oncologist will schedule regular blood tests and other assessments to monitor your response to
Imat imatinib therapy and adjust doses if needed.

Precautions

Before starting Imat, inform your doctor about your complete medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of liver disease, kidney impairment or significant cardiac disease
• Pre-existing fluid retention, swelling, heart failure or shortness of breath
• Previous or current gastrointestinal bleeding, ulcers or major stomach or bowel disease
• Use of other anticancer medicines, immunosuppressants or biologic therapies
• Use of strong CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with imatinib
• Use of paracetamol, anticoagulants or other medicines that may require careful monitoring with Imat imatinib tablets

Imatinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Imat. Your specialist will set an appropriate monitoring schedule in your case.

Imatinib Side Effects

Common side effects

Many patients experience side effects when starting Imat imatinib tablets, especially during the first months of treatment. Common reactions may include:

• Nausea, mild vomiting or stomach discomfort
• Diarrhea or, in some cases, constipation
• Fluid retention with swelling of ankles, legs or around the eyes
• Muscle cramps, bone pain or joint discomfort
• Fatigue, weakness or general tiredness
• Mild skin rash or itching

These side effects are often manageable with supportive care or dose adjustments, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of imatinib are less common but more serious and require urgent medical attention. Serious reactions may include:

• Marked fluid retention with sudden weight gain, worsening shortness of breath or pronounced leg swelling
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe abdominal pain, bloody stools or vomiting blood, which may indicate serious gastrointestinal issues
• Significant changes in blood counts, with fever, frequent infections, unusual bruising or prolonged bleeding
• Severe skin reactions, widespread rash, blistering or involvement of the mouth or eyes

If you experience any of these serious symptoms while taking Imat 100 mg or Imat 400 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Imat tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the tablets in their original blisters and cartons until use to protect them from moisture and light.
• Keep Imat imatinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired imatinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Imat 100 mg and Imat 400 mg imatinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Imat online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic imatinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your haematologist or oncologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Imat 100 mg and 400 mg imatinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of a haematologist or oncologist.
Before you order Imat online, ensure that you have a valid prescription or written treatment plan specifying imatinib, the required daily dose and intended duration of therapy.

Select the prescribed strength — Imat 100 mg (1 pack / 10 tablets) or Imat 400 mg (1 pack / 10 tablets) —
choose the appropriate quantity, add Imat to your cart and complete the secure checkout process. Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.

Regonat Regorafenib – 40 mg (1 pack / 28 tablets)

At a Glance

Generic Name: Regorafenib

Brand Name: Regonat

Strength & Pack Size: Regonat 40 mg – 1 pack / 28 tablets

Dosage Form: Oral film-coated tablets

Therapeutic Class: Multikinase inhibitor, targeted anticancer therapy

Main Indications: Metastatic colorectal cancer, unresectable gastrointestinal stromal tumours (GIST) and hepatocellular carcinoma as indicated

Use in Therapy: Systemic oral treatment for unresectable or metastatic disease after prior lines of therapy

Prescription Status: Prescription-only oncology medicine

Supplied By: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from light and moisture

Product Description

Regonat 40 mg contains regorafenib, an oral multikinase inhibitor used as targeted therapy in selected patients with advanced solid tumours.
It is commonly prescribed for metastatic colorectal cancer, unresectable gastrointestinal stromal tumours (GIST) and hepatocellular carcinoma after
standard options have failed or are no longer effective. Regonat regorafenib 40 mg tablets act on multiple signalling pathways involved in tumour growth and tumour angiogenesis,
helping to slow disease progression under specialist supervision.

Each Regonat 40 mg tablet contains 40 mg of regorafenib, and the 1 pack / 28 tablets presentation aligns with typical 28-day treatment cycles
(three weeks on therapy followed by one week off) used in many protocols. As a generic regorafenib 40 mg product, Regonat offers the same active ingredient and strength
as originator regorafenib while providing a more accessible price in USD for patients requiring repeated cycles of targeted therapy.

When you buy Regonat 40 mg online from Generic Meds Mart, you receive regorafenib 40 mg tablets in original manufacturer packaging with clear labelling, batch number and expiry date.
We source Regonat only from licensed manufacturers and authorised distributors that follow recognised GMP standards. Our role is limited to safe, structured supply; all treatment decisions remain with your oncology team.

Key Uses

Regonat 40 mg regorafenib tablets are generally used under specialist supervision for:

• Metastatic colorectal cancer in adults previously treated with standard chemotherapy and targeted agents
• Unresectable or metastatic gastrointestinal stromal tumours (GIST) after failure or intolerance of other tyrosine kinase inhibitors
• Hepatocellular carcinoma in patients who have received prior systemic therapy when regorafenib is recommended

Your oncologist will determine whether Regonat 40 mg is appropriate based on tumour type, prior treatments, liver function and current guidelines.

How Regorafenib Works in Chemotherapy

Regorafenib is an oral targeted anticancer medicine from the class of multikinase inhibitors.
Although often grouped with modern systemic chemotherapy, Regonat regorafenib does not act like classic cytotoxic drugs that directly damage DNA.
Instead, it blocks multiple protein kinases that regulate tumour cell proliferation and tumour blood vessel formation.

Regonat 40 mg regorafenib tablets inhibit kinases including RAF family members and receptors in the VEGFR and PDGFR pathways.
These kinases drive tumour growth and angiogenesis in many colorectal cancers, GIST and hepatocellular carcinomas. By targeting these pathways,
Regonat 40 mg exerts both antiproliferative and anti-angiogenic effects, helping to slow tumour growth and reduce tumour blood supply.

Because these pathways also exist in healthy tissues, regorafenib therapy can cause systemic side effects, making regular monitoring by an experienced oncologist essential throughout treatment.

Dosage & Administration

The dosing schedule for Regonat 40 mg regorafenib tablets must always follow your oncology team’s instructions.
Many regorafenib protocols use a 28-day cycle with treatment given for three weeks followed by a one-week break, but exact doses and cycle numbers vary.

• Take Regonat tablets exactly as prescribed, at the same time each treatment day.
• Swallow Regonat 40 mg tablets whole with water; do not crush, split or chew them unless your pharmacist advises otherwise.
• Your doctor may recommend taking regorafenib 40 mg after a low-fat meal to support consistent absorption.
• Do not change the number of tablets, alter cycle patterns or stop Regonat on your own.
• If you miss a dose, follow written instructions from your treatment centre; do not double the next dose unless your doctor specifically instructs you to.

Regular blood tests, blood pressure checks and clinical visits are required so your oncology team can assess response and adjust Regonat 40 mg therapy if needed.

Precautions

Before starting Regonat 40 mg, tell your doctors about your full medical history and all medicines, supplements and herbal products you use. Important precautions include:

• Pre-existing liver disease, cirrhosis, viral hepatitis or abnormal liver function tests
• History of hypertension, coronary artery disease, heart failure or arterial clotting events
• Recent major surgery or planned operations, due to potential effects on wound healing
• Previous bleeding disorders, gastrointestinal ulcers, perforation or varices
• Use of anticoagulants or antiplatelet medicines that may increase bleeding risk
• Use of strong inducers or inhibitors of drug-metabolising enzymes that may alter regorafenib levels
• Pregnancy or breastfeeding; regorafenib tablets are not recommended and may harm an unborn baby

Men and women of child-bearing potential are usually advised to use effective contraception during and for a period after Regonat regorafenib treatment, as directed by their oncologist.

Regorafenib Side Effects

Common side effects

Common side effects of Regonat 40 mg regorafenib tablets include:

• Hand–foot skin reaction (redness, pain, thickening on palms and soles)
• Rash, dry skin or itching
• Fatigue, asthenia or low energy
• Diarrhea or loose stools
• Nausea, occasional vomiting or reduced appetite
• Abdominal discomfort or pain
• Hoarseness or voice changes
• Mild to moderate increases in blood pressure

These effects are often manageable with supportive care, blood pressure control, dermatologic treatment and dose modifications, as decided by your oncology team.

Serious side effects

Serious side effects of regorafenib require urgent medical attention and may include:

• Severe or uncontrolled hypertension, chest pain or shortness of breath
• Significant bleeding, such as black or bloody stools, vomiting blood or coughing up blood
• Signs of severe liver injury: yellowing of the skin or eyes, dark urine, pale stools, intense upper abdominal pain
• Severe, persistent abdominal pain that may indicate gastrointestinal perforation
• Severe hand–foot skin reaction with blistering or extensive peeling
• Sudden severe headache, vision changes or neurological symptoms suggestive of a vascular event

If you experience any of these symptoms while taking Regonat 40 mg, seek emergency medical care immediately and contact your oncology team.

Storage

• Store Regonat 40 mg regorafenib tablets at room temperature, preferably below 25 °C.
• Keep tablets in their original blisters and carton to protect them from moisture and light.
• Keep all anticancer medicines out of the sight and reach of children and pets.
• Do not use after the expiry date printed on the packaging.

Ask your pharmacist or oncology centre how to safely dispose of unused or expired Regonat regorafenib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart is dedicated to providing safe access to key oncology medicines such as
Regonat 40 mg regorafenib tablets at transparent prices in USD.
We source only from licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a reliable export record.

When you buy Regonat 40 mg online from Generic Meds Mart, you benefit from:

• Discreet, plain outer packaging for international delivery
• Clear, structured information about regorafenib 40 mg tablets to support discussions with your oncology team
• Tracked shipping options to many destinations
• Customer support for questions about ordering, payment and delivery

Order Now

Regonat 40 mg regorafenib tablets are prescription-only targeted anticancer medicines and must be used strictly under specialist supervision.
Before you order Regonat online, ensure your oncologist has confirmed regorafenib as part of your treatment plan and specified the total daily dose and number of packs required.

Select Regonat 40 mg (1 pack / 28 tablets), choose the quantity that matches your written plan, add it to your cart and complete the secure checkout on Generic Meds Mart.
Your order will be processed, packed discreetly and shipped with tracking where available. All treatment decisions and dose adjustments must remain with your healthcare team.

Imatib Imatinib – 100 mg (1 pack / 10 tablets)

At a Glance

Brand name: Imatib

Generic name: Imatinib mesylate

Active ingredient: Imatinib

Strength & pack size: Imatib 100 mg (1 pack / 10 tablets)

Dosage form: Oral film-coated tablets

Main indication: Philadelphia chromosome–positive chronic myeloid leukemia (CML) and selected gastrointestinal stromal tumors (GIST)

Therapeutic class: Tyrosine kinase inhibitor (TKI)

Use in therapy: Targeted systemic treatment for Ph+ CML and indicated solid tumors

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Imatib 100 mg tablets are a generic imatinib mesylate medicine used in the treatment of specific blood cancers and solid tumors.
Imatinib is a well-known tyrosine kinase inhibitor (TKI) that has transformed outcomes for patients with
Philadelphia chromosome–positive chronic myeloid leukemia (CML) and certain gastrointestinal stromal tumors (GIST).
Imatib 100 mg (1 pack / 10 tablets) offers a compact pack size that may be used as an initial supply, a short bridging course or as continuation therapy,
always according to your specialist’s prescription.

Each Imatib tablet contains 100 mg of imatinib, taken by mouth, usually once or twice daily depending on the required total daily dose.
The 100 mg strength provides flexibility for dose titration and individualised treatment regimens. Because
Imatib is a generic imatinib product, it contains the same active ingredient as branded imatinib while offering a more accessible price in USD,
which can be important for patients who need long-term imatinib therapy.

When you buy Imatib 100 mg online from Generic Meds Mart, you receive imatinib tablets supplied by licensed manufacturers and authorised distributors
that follow recognised GMP standards. The medicine is shipped in plain, discreet outer packaging, while original blisters and cartons maintain full details such as strength, batch number and expiry date.

This Imatib 100 mg (1 pack / 10 tablets) product is intended only for patients already under the care of a haematologist or oncologist who has recommended
imatinib tablets as part of a treatment plan. Generic Meds Mart does not diagnose conditions or change treatment protocols;
the information on this page is designed to support informed discussions with your specialist about access to generic imatinib.

Key Uses

Imatib 100 mg imatinib tablets are typically used for the following indications under specialist supervision:

• Treatment of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in chronic, accelerated or blast phase as directed
• Treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in selected patients
• Treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) expressing KIT (CD117) or other relevant targets
• Treatment of other rare malignancies where imatinib is specifically recommended in recognised oncology guidelines

Your specialist will determine how Imatib 100 mg fits into your therapy, what total daily dose you need and how long
imatinib treatment should continue.

How Imatinib Works in Chemotherapy

Imatinib is a targeted anticancer agent often grouped within modern systemic chemotherapy and targeted therapy regimens.
Imatib 100 mg contains imatinib, a tyrosine kinase inhibitor (TKI) that blocks abnormal signalling from specific tyrosine kinases such as BCR-ABL in CML
and KIT in many GIST tumours.

Imatib imatinib tablets work by binding to these overactive kinases and blocking their ATP-binding sites.
This disrupts the signalling pathways that drive uncontrolled cancer cell growth and survival. In
chronic myeloid leukemia, this targeted inhibition can reduce leukemic cell counts and support long-term disease control.
In GIST, inhibition of KIT may shrink or stabilise tumours that depend on this pathway.

Because imatinib acts as a targeted TKI rather than a traditional cytotoxic drug, its side effect profile differs from standard chemotherapy.
However, Imatib 100 mg is still a potent anticancer medicine that must be monitored carefully by an experienced haematologist or oncologist.

Dosage & Administration

Imatib 100 mg imatinib tablets must always be taken exactly as prescribed by your specialist.
Daily dosing, timing and duration of therapy depend on your diagnosis, disease phase, response and tolerance.

• Take Imatib tablets by mouth with a large glass of water; many patients are advised to take doses with food to reduce stomach discomfort.
• Swallow the tablets whole. Do not crush, split or chew Imatib 100 mg tablets unless your doctor or pharmacist has given specific instructions.
• The total daily dose may be taken once daily or divided into two doses, depending on your prescription and how well you tolerate treatment.
• Do not change your dose or stop taking Imatib without clear instructions from your haematologist or oncologist.
• If you miss a dose, follow your doctor’s advice; do not double the next dose to compensate unless your specialist has recommended it.

Your oncology team will schedule regular blood tests and other assessments to monitor your response to
Imatib imatinib therapy and to guide any necessary dose adjustments.

Precautions

Before starting Imatib 100 mg, inform your doctor about your full medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of liver disease, kidney impairment or significant cardiac disease
• Pre-existing fluid retention, swelling, heart failure or shortness of breath
• Previous or current gastrointestinal bleeding, ulcers or serious stomach or bowel conditions
• Use of other anticancer medicines, immunosuppressants or biologic therapies
• Use of strong CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with imatinib
• Use of paracetamol, anticoagulants or other medicines that may require careful monitoring with Imatib imatinib tablets

Imatinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Imatib. Your specialist will set an appropriate monitoring schedule in your case.

Imatinib Side Effects

Common side effects

Many patients experience side effects when starting Imatib imatinib tablets, especially during the first months of treatment. Common reactions may include:

• Nausea, mild vomiting or stomach discomfort
• Diarrhea or, in some cases, constipation
• Fluid retention with swelling of ankles, legs or around the eyes
• Muscle cramps, bone pain or joint discomfort
• Fatigue, weakness or general tiredness
• Mild skin rash or itching

These side effects are often manageable with supportive care or dose adjustments, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of imatinib are less common but more serious and require urgent medical attention. Serious reactions may include:

• Marked fluid retention with sudden weight gain, worsening shortness of breath or pronounced leg swelling
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe abdominal pain, bloody stools or vomiting blood, which may indicate serious gastrointestinal issues
• Significant changes in blood counts, with fever, frequent infections, unusual bruising or prolonged bleeding
• Severe skin reactions, widespread rash, blistering or involvement of the mouth or eyes

If you experience any of these serious symptoms while taking Imatib 100 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Imatib 100 mg tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the tablets in their original blisters and carton until use to protect them from moisture and light.
• Keep Imatib imatinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired imatinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Imatib 100 mg imatinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Imatib 100 mg online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic imatinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your haematologist or oncologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Imatib 100 mg imatinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of a haematologist or oncologist.
Before you order Imatib 100 mg online, ensure that you have a valid prescription or written treatment plan specifying imatinib, the required daily dose and intended duration of therapy.

Select Imatib 100 mg (1 pack / 10 tablets), choose the appropriate quantity, add Imatib to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.